Literature DB >> 30716714

Volume effect in paediatric brain tumour resection surgery: analysis of data from the Japanese national inpatient database.

Daisuke Shinjo1, Kimikazu Matsumoto2, Keita Terashima2, Tetsuya Takimoto2, Tetsu Ohnuma3, Takashi Noguchi1, Kiyohide Fushimi4.   

Abstract

BACKGROUND: Paediatric brain tumours are the second most common type of malignancies that occur during childhood. Surgical resection is usually the first step in the treatment of these patients; however, evidence pertaining to a 'volume effect' in paediatric brain tumour resection surgery and the associations among the surgical volume, clinical features and treatments are not well characterised.
METHODS: Data pertaining to paediatric patients (age ≤ 15 years) who underwent brain tumour resection surgery between April 2012 and March 2016 were retrieved from the Japanese administrative inpatient database and retrospectively analysed. Demographic characteristics, therapeutic procedures and in-hospital mortality were summarised according to the hospital surgical volume. Penalised logistic regression analysis was used to investigate the association between the hospital surgical volume and in-hospital mortality.
RESULTS: A total of 1354 paediatric patients were included. About 40% of the patients were in the 11- to 15-year age group. The male:female ratio was 53:47, the overall crude in-hospital mortality was 1.8% (n = 24) and the 30-day postoperative mortality was 0.4% (n = 6). The crude mortality ratio was 3.3% in the lowest quartile and 0.8% in the highest quartile by volume. After adjusting for covariates, a higher hospital surgical volume was associated with lower in-hospital mortality (compared with 1-4 surgeries per 4 years, 15-25 surgeries, odds ratio [OR]: 0.25; 95% confidence interval [CI]: 0.05-0.90, p = 0.033; ≥26 surgeries, OR: 0.31; 95% CI: 0.08-0.96, p = 0.042).
CONCLUSIONS: The present study indicated a volume-outcome relationship in paediatric brain tumour resection surgery cases. Further centralisation of surgeries should be considered to achieve better outcomes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Administrative database; Brain tumour; DPC; Japan; Paediatric; Resection surgery

Mesh:

Year:  2019        PMID: 30716714     DOI: 10.1016/j.ejca.2018.12.030

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States.

Authors:  Koji Matsuo; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Maximilian Klar; Brendan H Grubbs; Lynda D Roman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2020-01-22       Impact factor: 5.482

2.  Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database.

Authors:  Takehiko Oami; Taro Imaeda; Taka-Aki Nakada; Toshikazu Abe; Nozomi Takahashi; Yasuo Yamao; Satoshi Nakagawa; Hiroshi Ogura; Nobuaki Shime; Yutaka Umemura; Asako Matsushima; Kiyohide Fushimi
Journal:  J Intensive Care       Date:  2022-07-14

Review 3.  Existing Data Sources for Clinical Epidemiology: Database of the National Hospital Organization in Japan.

Authors:  Natsuko Kanazawa; Takuaki Tani; Shinobu Imai; Hiromasa Horiguchi; Kiyohide Fushimi; Norihiko Inoue
Journal:  Clin Epidemiol       Date:  2022-05-19       Impact factor: 5.814

4.  Pandemic-resilient target setting in colorectal cancer screening for vulnerable older population.

Authors:  Toshiaki Shibata; Daisuke Shinjo; Junichi Takahashi; Kiyohide Fushimi
Journal:  Cancer Med       Date:  2022-06-05       Impact factor: 4.711

5.  Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study.

Authors:  Nobuyuki Yotani; Daisuke Shinjo; Motohiro Kato; Kimikazu Matsumoto; Kiyohide Fushimi; Yoshiyuki Kizawa
Journal:  BMC Palliat Care       Date:  2021-06-07       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.